Abstract
Epigenetic alterations in DNA methylation might mediate gene expression effects of trauma underlying PTSD symptoms, or effects of PTSD on related health problems. PTSD is associated with all-cause morbidity and premature mortality, suggesting accelerated biological aging. We measured genome-wide DNA methylation (Illumina MethylationEPIC BeadChip) in whole blood in a treatment study for combat-related PTSD - “PROGrESS”, a multisite RCT comparing sertraline plus enhanced medication management (SERT + EMM), prolonged exposure (PE) therapy plus placebo (PE + PLB), and the combination (SERT + PE). DNA methylation was measured in 140 US military veterans who served in Iraq and/or Afghanistan (112 current PTSD cases enrolled in a PTSD treatment study and 28 veterans without PTSD history controls), and also 59 non-trauma exposed controls at baseline posttreatment (24 weeks after baseline). Increased DNA methylation GrimAge acceleration (p = 8.8e−09) was observed in patients with PTSD compared to a pooled control group (trauma exposed and non-trauma exposed), suggesting a higher risk of premature mortality in those with PTSD. There was no difference in GrimAge acceleration between combat trauma and non-trauma exposed controls. No treatment-related changes in GrimAge acceleration were found in within-subject comparisons of PTSD patients pre- to post-treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 773-780 |
Number of pages | 8 |
Journal | Neuropsychopharmacology |
Volume | 48 |
Issue number | 5 |
DOIs | |
State | Published - Apr 2023 |
Keywords
- Humans
- Aging
- DNA Methylation
- Military Personnel
- Sertraline/therapeutic use
- Stress Disorders, Post-Traumatic/genetics
- Veterans
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology